{"id":"https://openalex.org/W229815988","doi":"https://doi.org/10.1021/acs.jmedchem.5b00067","title":"Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells","display_name":"Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells","publication_year":2015,"publication_date":"2015-05-12","ids":{"openalex":"https://openalex.org/W229815988","doi":"https://doi.org/10.1021/acs.jmedchem.5b00067","mag":"229815988","pmid":"https://pubmed.ncbi.nlm.nih.gov/25965804"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.5b00067","doi":"https://doi.org/10.1021/acs.jmedchem.5b00067","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.5b00067","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.osti.gov/servlets/purl/1240168","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065152783","display_name":"James R. Henry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James R. Henry","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050197824","display_name":"Michael D. Kaufman","orcid":"https://orcid.org/0000-0003-1325-5849","observed_orcids":["https://orcid.org/0000-0003-1325-5849"]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael D. Kaufman","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027129499","display_name":"Sheng-Bin Peng","orcid":"https://orcid.org/0009-0006-2498-4253","observed_orcids":["https://orcid.org/0009-0006-2498-4253","https://orcid.org/0000-0002-9822-8534"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheng-Bin Peng","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109916810","display_name":"Yu Mi Ahn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Mi Ahn","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111628533","display_name":"Timothy M. Caldwell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy M. Caldwell","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045394985","display_name":"Lakshminarayana Vogeti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lakshminarayana Vogeti","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113215860","display_name":"Hanumaiah Telikepalli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hanumaiah Telikepalli","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103252789","display_name":"Wei-Ping Lu","orcid":"https://orcid.org/0000-0002-6322-6897","observed_orcids":["https://orcid.org/0000-0002-6322-6897"]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei-Ping Lu","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068901792","display_name":"Molly M. Hood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Molly M. Hood","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037605629","display_name":"Thomas J. Rutkoski","orcid":"https://orcid.org/0009-0004-1958-9051","observed_orcids":["https://orcid.org/0009-0004-1958-9051"]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Rutkoski","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111867939","display_name":"Bryan D. Smith","orcid":"https://orcid.org/0009-0002-7666-7517","observed_orcids":["https://orcid.org/0009-0002-7666-7517"]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bryan D. Smith","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002442258","display_name":"Subha Vogeti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Subha Vogeti","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Miller","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030901865","display_name":"Scott Wise","orcid":"https://orcid.org/0000-0003-2078-8758","observed_orcids":["https://orcid.org/0000-0003-2078-8758"]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott C. Wise","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026257525","display_name":"Lawrence Chun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence Chun","raw_affiliation_strings":["Emerald Biostructures, Bainbridge Island, Washington 98110, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emerald Biostructures, Bainbridge Island, Washington 98110, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100357472","display_name":"Xiaoyi Zhang","orcid":"https://orcid.org/0000-0002-8021-1953","observed_orcids":["https://orcid.org/0000-0002-8021-1953"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoyi Zhang","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045686903","display_name":"Youyan Zhang","orcid":"https://orcid.org/0009-0000-9945-8377","observed_orcids":["https://orcid.org/0009-0000-9945-8377"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Youyan Zhang","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011118925","display_name":"Lisa M. Kays","orcid":"https://orcid.org/0009-0007-9343-7314","observed_orcids":["https://orcid.org/0009-0007-9343-7314"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Kays","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012426969","display_name":"Philip A. Hipskind","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip A. Hipskind","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030748103","display_name":"Aaron D. Wrobleski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron D. Wrobleski","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018188905","display_name":"Karen L. Lobb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen L. Lobb","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077883271","display_name":"Julia M. Clay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia M. Clay","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023579003","display_name":"Jeffrey D. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey D. Cohen","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032438879","display_name":"Jennie Walgren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennie L. Walgren","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044441430","display_name":"Denis McCann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denis McCann","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109988011","display_name":"Phenil J. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phenil Patel","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045983438","display_name":"David K. Clawson","orcid":"https://orcid.org/0000-0002-1593-0214","observed_orcids":["https://orcid.org/0000-0002-1593-0214"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David K. Clawson","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071524734","display_name":"Sherry Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sherry Guo","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043580015","display_name":"Danalyn Manglicmot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danalyn Manglicmot","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037651093","display_name":"Chris Groshong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris Groshong","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005619983","display_name":"Cheyenne Logan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheyenne Logan","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108363588","display_name":"James J. Starling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James J. Starling","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103397917","display_name":"Daniel Lee Flynn","orcid":"https://orcid.org/0000-0002-3752-7370","observed_orcids":["https://orcid.org/0000-0002-3752-7370"]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel L. Flynn","raw_affiliation_strings":["Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts 02451, United States","institution_ids":["https://openalex.org/I4210127537"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5065152783"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":4.9173,"has_fulltext":true,"cited_by_count":86,"citation_normalized_percentile":{"value":0.96199212,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"58","issue":"10","first_page":"4165","last_page":"4179"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ly3009120","display_name":"LY3009120","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pan-raf-inhibitor","display_name":"pan-RAF inhibitor","score":0.9110000133514404},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.8399999737739563},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.7110000252723694},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.949999988079071},{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6629999876022339},{"id":"https://openalex.org/keywords/kras","display_name":"KRAS","score":0.5180000066757202},{"id":"https://openalex.org/keywords/nras","display_name":"NRAS","score":0.9890000224113464},{"id":"https://openalex.org/keywords/raf-1","display_name":"Raf-1","score":0.503000020980835},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.40700000524520874},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.8323990106582642},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.8228819966316223},{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.7186242938041687},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7056202292442322},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6821047067642212},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6780209541320801},{"id":"https://openalex.org/C2776470698","wikidata":"https://www.wikidata.org/wiki/Q21851559","display_name":"V600E","level":4,"score":0.6576509475708008},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.6096276640892029},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5702060461044312},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5430623292922974},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4924364984035492},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4019835293292999},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37425386905670166},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18914183974266052},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.17172956466674805},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1439838707447052},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12991991639137268},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08615231513977051},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07917535305023193}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019908","descriptor_name":"Proto-Oncogene Proteins c-raf","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060326","descriptor_name":"Chemistry Techniques, Synthetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.jmedchem.5b00067","doi":"https://doi.org/10.1021/acs.jmedchem.5b00067","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.5b00067","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:25965804","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25965804","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:osti.gov:1240168","doi":null,"is_oa":true,"landing_page_url":"https://www.osti.gov/biblio/1240168","pdf_url":"https://www.osti.gov/servlets/purl/1240168","source":{"id":"https://openalex.org/S4306402487","display_name":"OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139351228","host_organization_name":"Office of Scientific and Technical Information","host_organization_lineage":["https://openalex.org/I139351228"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:osti.gov:1240168","doi":null,"is_oa":true,"landing_page_url":"https://www.osti.gov/biblio/1240168","pdf_url":"https://www.osti.gov/servlets/purl/1240168","source":{"id":"https://openalex.org/S4306402487","display_name":"OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139351228","host_organization_name":"Office of Scientific and Technical Information","host_organization_lineage":["https://openalex.org/I139351228"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7799999713897705,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G102163711","display_name":null,"funder_award_id":"DE\u2010 AC02\u201006CH11357","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G107546177","display_name":null,"funder_award_id":"DE- AC02-06-CH11357","funder_id":"https://openalex.org/F4320338284","funder_display_name":"Argonne National Laboratory"},{"id":"https://openalex.org/G1313983767","display_name":null,"funder_award_id":"DE-AC02","funder_id":"https://openalex.org/F4320338284","funder_display_name":"Argonne National Laboratory"},{"id":"https://openalex.org/G1664757510","display_name":null,"funder_award_id":"AC02\u201306CH11357","funder_id":"https://openalex.org/F4320338284","funder_display_name":"Argonne National Laboratory"},{"id":"https://openalex.org/G2287611682","display_name":null,"funder_award_id":"AC02\u201006CH11357","funder_id":"https://openalex.org/F4320332359","funder_display_name":"Office of Science"},{"id":"https://openalex.org/G262962599","display_name":null,"funder_award_id":"AC02\u201006CH11357","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G3075337988","display_name":null,"funder_award_id":"06CH11357","funder_id":"https://openalex.org/F4320338284","funder_display_name":"Argonne National Laboratory"},{"id":"https://openalex.org/G498139845","display_name":null,"funder_award_id":"DE-AC02","funder_id":"https://openalex.org/F4320332359","funder_display_name":"Office of Science"},{"id":"https://openalex.org/G6848031779","display_name":null,"funder_award_id":"06CH11357","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G6918803902","display_name":null,"funder_award_id":"06CH11357","funder_id":"https://openalex.org/F4320332359","funder_display_name":"Office of Science"},{"id":"https://openalex.org/G969889393","display_name":null,"funder_award_id":"DE-AC02-","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G993149817","display_name":null,"funder_award_id":"DE-AC02-06CH11357 ","funder_id":"https://openalex.org/F4320332359","funder_display_name":"Office of Science"}],"funders":[{"id":"https://openalex.org/F4320306084","display_name":"U.S. Department of Energy","ror":"https://ror.org/01bj3aw27"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320332359","display_name":"Office of Science","ror":"https://ror.org/00mmn6b08"},{"id":"https://openalex.org/F4320338284","display_name":"Argonne National Laboratory","ror":"https://ror.org/05gvnxz63"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W229815988.pdf","grobid_xml":"https://content.openalex.org/works/W229815988.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1603855465","https://openalex.org/W1922606988","https://openalex.org/W1930191579","https://openalex.org/W1934657686","https://openalex.org/W1970527559","https://openalex.org/W2002143632","https://openalex.org/W2004295816","https://openalex.org/W2011780255","https://openalex.org/W2044594845","https://openalex.org/W2046514328","https://openalex.org/W2051165598","https://openalex.org/W2071018921","https://openalex.org/W2080626878","https://openalex.org/W2106543129","https://openalex.org/W2113782793","https://openalex.org/W2128542677","https://openalex.org/W2133177414","https://openalex.org/W2142019721","https://openalex.org/W2144708319","https://openalex.org/W2149662085","https://openalex.org/W2154929109","https://openalex.org/W2166229764","https://openalex.org/W2166262263","https://openalex.org/W2401285046","https://openalex.org/W4210982805"],"related_works":["https://openalex.org/W1984623460","https://openalex.org/W2687379338","https://openalex.org/W1940641879","https://openalex.org/W2908127640","https://openalex.org/W2496593006","https://openalex.org/W7008938824","https://openalex.org/W1949194567","https://openalex.org/W2894493431","https://openalex.org/W2793233777","https://openalex.org/W4282918779"],"abstract_inverted_index":{"The":[0,16],"RAS-RAF-MEK-MAPK":[1],"cascade":[2],"is":[3,142],"an":[4],"essential":[5],"signaling":[6],"pathway,":[7],"with":[8,55,69,75,87,99],"activation":[9,91],"typically":[10],"mediated":[11],"through":[12],"cell":[13],"surface":[14],"receptors.":[15],"kinase":[17],"inhibitors":[18],"vemurafenib":[19],"and":[20,50,61,92,120,130,141],"dabrafenib,":[21],"which":[22],"target":[23],"oncogenic":[24],"BRAF":[25,70,113,119],"V600E,":[26],"have":[27],"shown":[28],"significant":[29],"clinical":[30,149],"efficacy":[31],"in":[32,58,128,131,146],"melanoma":[33],"patients":[34,68,74,98],"harboring":[35],"this":[36],"mutation.":[37],"Because":[38],"of":[39,52,66,125],"paradoxical":[40,88],"pathway":[41,90],"activation,":[42],"both":[43],"agents":[44],"were":[45],"demonstrated":[46],"to":[47,82,93,97,105],"promote":[48],"growth":[49],"metastasis":[51],"tumor":[53],"cells":[54],"RAS":[56,100],"mutations":[57],"preclinical":[59],"models":[60],"are":[62],"contraindicated":[63],"for":[64,138],"treatment":[65],"cancer":[67],"WT":[71],"background,":[72],"including":[73],"KRAS":[76],"or":[77],"NRAS":[78],"mutations.":[79],"In":[80],"order":[81],"eliminate":[83],"the":[84,123],"issues":[85],"associated":[86],"MAPK":[89],"provide":[94],"therapeutic":[95],"benefit":[96],"mutant":[101],"cancers,":[102],"we":[103],"sought":[104],"identify":[106],"a":[107],"compound":[108,134],"not":[109],"only":[110],"active":[111],"against":[112],"V600E":[114],"but":[115],"also":[116],"wild":[117],"type":[118],"CRAF.":[121],"On":[122],"basis":[124],"its":[126],"superior":[127],"vitro":[129],"vivo":[132],"profile,":[133],"13":[135],"was":[136],"selected":[137],"further":[139],"development":[140],"currently":[143],"being":[144],"evaluated":[145],"phase":[147],"I":[148],"studies.":[150]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}